Coinbase: Analysts Expect $1.57 Billion In Q3 Revenues

Coinbase Global Inc (NASDAQ: COIN) is expected to report its third quarter 2021 financial results on November 9, 2021 after the market closes.

Analysts have a consensus US$382.65 12-month price target on the company, via a total of 23 analysts, with 6 analysts having strong buy ratings, 11 have buy ratings, 5 analysts have holds and a single analyst has a sell rating on the stock. The street high comes from Moffettnathanson with a US$600 price target, and the lowest target sits at US$250.

20 analysts have revenue estimates for the third quarter. The mean between all 20 is US$1.57 billion; this number has been revised upwards from US$1.09 billion at the start of May. The street high is US$2.14 billion while the lowest sits at US$648 million.

Only 3 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 89%; this number has been revised upwards from 86% at the start of May. Street high is a 92% estimate and the lowest sits at 86%.

Onto EBITDA estimates, there are currently 14 analysts who have third-quarter EBITDA estimates. The mean is currently US$662.58 million, with this number being revised upwards from US$391.5 million at the start of May. Street high sits at US$1.06 billion EBITDA and the lowest is a US$323.7 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver @ $36 & We’re Still 200M Oz Short | Paul Andre Huet – Americas Gold and Silver

Gold’s Wild Bull Run: Are Markets About to Break? | Mike McGlone

First Majestic Silver: The Santa Elena Mine

Recommended

Goliath Resources Closes Out Funding Round With Total Gross Proceeds Of $27.1 Million

Silver47 Kickstarts 4,000 Metre Drill Campaign At Red Mountain Project

Related News

Curaleaf: Haywood Reiterates $22 Price Target, Names Firm A Top Pick For 2022

On December 28th, Curaleaf Holdings (CSE: CURA) announced that they have entered into a definitive agreement...

Friday, December 31, 2021, 04:35:00 PM

Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50

Earlier this week, Antibe Therapeutics (TSXV: ATE) announced a strategic licensing deal with Nuance Pharm...

Thursday, February 11, 2021, 04:07:00 PM

Coinbase: Investors Shrug Off SEC Risk Amid Crypto Crackdown

Coinbase Global, Inc. (NASDAQ: COIN) has been one of the best performers in the market’s...

Monday, January 16, 2023, 06:34:00 AM

Galaxy Digital: BMO Cuts Price Target To $14 After BitGo Purchase Falls Apart

Galaxy Digital (TSX: GLXY) yesterday announced that it would be terminating its acquisition of BitGo...

Tuesday, August 16, 2022, 12:26:49 PM

Docusign: Analysts Anticipate $437.8 Million In Q1 Revenues

Docusign (NASDAQ: DOCU) will be reporting their first quarter 2022 financial results today after market...

Thursday, June 3, 2021, 11:15:00 AM